Companies: 11,396     total market cap: ยฃ112.080 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณ$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alnylam Pharmaceuticals
ALNY
#1149
Rank
ยฃ15.22 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
ยฃ113.67
Share price
-3.17%
Change (1 day)
-66.10%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2026 : ยฃ2.70 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has ยฃ2.70 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-ยฃ0.18 Billion32.42%
2022-12-31$-ยฃ0.14 Billion-130.01%
2021-12-31$ยฃ0.43 B-41.55%
2020-12-31$ยฃ0.74 B-32.05%
2019-12-31$ยฃ1.09 B6.97%
2018-12-31$ยฃ1.02 B-21.52%
2017-12-31$ยฃ1.30 B75.25%
2016-12-31$ยฃ0.74 B-12.61%
2015-12-31$ยฃ0.85 B41.92%
2014-12-31$ยฃ0.60 B266.92%
2013-12-31$ยฃ0.16 B97.61%
2012-12-31$ยฃ82.93 M9.25%
2011-12-31$ยฃ75.91 M-25.94%
2010-12-31$ยฃ0.10 B-6.8%
2009-12-31$ยฃ0.10 B-20.26%
2008-12-31$ยฃ0.13 B37.56%
2007-12-31$ยฃ0.10 B-2.39%
2006-12-31$ยฃ0.10 B186.68%
2005-12-31$ยฃ35.82 M49.06%
2004-12-31$ยฃ24.03 M-260.98%
2003-12-31$-ยฃ14.94 Million415.26%
2002-12-31$-ยฃ2.9 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
ยฃ28.15 B 942.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ59.51 B 2,103.17%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
ยฃ23.77 B 779.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.14 B-57.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ51.74 M-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.88 B-67.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ5.81 B 115.24%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
ยฃ0.34 B-87.07%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com